Morgan Stanley Adjusts Price Target on Chubb to $360 From $350
Morgan Stanley raised its price target for Chubb from $350 to $360. UBS also adjusted its target to $380 from $369, maintaining a neutral rating. Chubb's stock is currently trading at $357.40, up 0.65% on the day and 14.38% year-to-date.
How this was made
The 30-second read
Why it matters
The higher target may attract new buying interest, but the effect could be muted if broader market sentiment is negative.
Market read
A modest analyst upgrade for a large‑cap insurer; likely limited but immediate impact on CB stock.
What to watch
Potential impact of upcoming regulatory changes on insurance pricing.
Background
Morgan Stanley updated its valuation model for Chubb, reflecting recent earnings and market conditions.
Ticker impact
Morgan Stanley raised Chubb's price target to $360 from $350.
potential upward pressure as investors price in the higher target.
The target increase reflects improved outlook; market may react positively in the short term.
Market effects
May lift sentiment in the insurance sector as peers could see similar re‑ratings.
U.S. market could see modest buying in financials.
Limited to investors tracking large‑cap insurers.
Counterpoint
The target raise could be premature if underwriting risks rise.
Key entities
- AnalystMorgan Stanley
Equity research firm providing the price target update.
- CompanyChubb Limited
U.S.-listed insurer (ticker CB) receiving the price target change.


